Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HLX02 vs Herceptin plus docetaxel in HER2-positive metastatic breast cancer
CTR20160526Phase 3Completed
- Sponsor
- Henlius
- Start
- Sep 2016
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of trastuzumab in breast cancer, sponsored by Henlius. Started Sep 2016; status: completed.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on CTR20160526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160526.